Comparison of CMV antigenaemia and quantitative realtime PCR CMV-DNA assay in the detection of CMV infection in patients after allogeneic haematopoietic stem cell transplantation

被引:0
|
作者
Gozdzik, J. [1 ]
Mordel, A. [1 ]
Lesko, E. [1 ]
Krasowska-Kwiecien, A. [1 ]
Kacinska, E. [1 ]
Wedrychowicz, A. [1 ]
Czogala, W. [1 ]
Wiecha, O. [1 ]
Skoczen, S. [1 ]
Majka, M. [1 ]
机构
[1] Jagiellonian Univ, Coll Med, Krakow, Poland
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S176 / S176
页数:1
相关论文
共 50 条
  • [21] Cytomegalovirus (CMV) infection in HIV/AIDS patients and diagnostic values of CMV-DNA detection across different sample types
    Zhao, Min
    Zhuo, Chuanshang
    Li, Qinguang
    Liu, Lijuan
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (05) : 2710 - 2715
  • [22] Risk Factors for Progression of CMV Viremia to CMV Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Mack, Johnathan P.
    Tan, Xianming
    Vinh, Donald C.
    Popradi, Gizelle
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S296 - S297
  • [23] USE OF CMV HYPERIMMUNOGLOBULINS (CYTOTECT) AS PREEMPTIVE TREATMENT OF CMV INFECTION IN PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION - A SINGLE CENTRE EXPERIENCE
    Desnica, Lana
    Durakovic, Nadira
    Peric, Zinaida
    Serventi-Seiwerth, Ranka
    Roncevic, Pavle
    Sertic, Dubravka
    Mikulic, Mirta
    Pulanic, Drazen
    Vrhovac, Radovan
    [J]. BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 430 - 431
  • [24] Clinical Outcome Associated with Cytomegalovirus (CMV) Infection/Disease in CMV-Seropositive Adult Patients after Allogeneic Hematopoietic Stem Cell Transplantation
    De latour, Regis Peffault
    Chevallier, Patrice
    Blaise, Didier
    Clement, Aurore
    Allavoine, Thierry
    Tadmouri, Abir
    Blomkvist, Josefin
    Duhamel, Alain
    Yakoub-Agha, Ibrahim
    [J]. BLOOD, 2018, 132
  • [25] Cytomegalovirus (CMV)-specific cytotoxic T lymphocyte therapy resolve CMV diseases and refractory CMV infections in paediatric recipients of allogeneic haematopoietic stem cell transplantation
    Wang, Xiaodong
    Yu, Uet
    Yang, Chunlan
    Wang, Chunjing
    Zhang, Xiaoling
    Li, Yue
    Li, Changgang
    Wen, Feiqiu
    Liu, Sixi
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (02) : 271 - 275
  • [26] Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease
    Bordon, V.
    Bravo, S.
    Van Renterghem, L.
    de Moerloose, B.
    Benoit, Y.
    Laureys, G.
    Dhooge, C.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2008, 10 (01) : 19 - 23
  • [27] Cytomegalovirus (CMV)-specific cytotoxic T lymphocyte therapy resolve CMV diseases and refractory CMV infections in paediatric recipients of allogeneic haematopoietic stem cell transplantation
    Xiaodong Wang
    Uet Yu
    Chunlan Yang
    Chunjing Wang
    Xiaoling Zhang
    Yue Li
    Changgang Li
    Feiqiu Wen
    Sixi Liu
    [J]. Bone Marrow Transplantation, 2022, 57 : 271 - 275
  • [28] Valganciclovir for the prophylaxis of early cytomegalovirus (CMV) infection after allogeneic stem cell transplantation
    Bachier, C
    Shaughnessy, P
    Wall, D
    Grimley, M
    Carrum, G
    Freytes, C
    Callander, N
    Walsh, T
    LeMaistre, CF
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 90 - 91
  • [29] CMV infection in seropositive patients with haematologic malignancies after allogeneic peripheral blood stem cell transplantation
    Tan, T.-D.
    [J]. BONE MARROW TRANSPLANTATION, 2009, 43 : S369 - S369
  • [30] Clinical aspects of CMV infection after stem cell transplantation
    Hebart, H
    Einsele, H
    [J]. HUMAN IMMUNOLOGY, 2004, 65 (05) : 432 - 436